Careful, Hoghead. You know what they say about Reindeer &
Careful, Hoghead. You know what they say about Reindeer & people who agree with him.
However, what is holding up finra? Is it meaningful/critical? Do we need to know what it is? Should we know what it is? We were told 7 days about 7 months ago, so, what gives, now. We all understood the debt issues, but, were under impression debt has been satisfied.
Great things are coming. We're all trying to estimate when. That's all.
Go ONCI
4
On4 Communications (ONCI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...
Continue Reading
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...
Continue Reading
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....
Continue Reading
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Top 5 Most Recently Viewed Articles
Milestone Scientific's Key Approval for CompuFlo® System Milestone Scientific Inc. (MLSS), a prominent name in the medical technology industry, has recently achieved a significant milestone by securing approval for the Federal Supply Schedule (FSS) concerning its CompuFlo® Epidural System. This news marks a substantial step for the company, which specializes in...
Continue Reading
Small Businesses Show Robust Resilience for 2026 As we approach a new year, the outlook for small businesses is remarkably positive, despite facing significant challenges from tariffs and inflation. The Comerica Small Business Pulse Index™ has released findings showcasing that small business owners nationwide are mostly hopeful about 2026, with many predicting growth...
Continue Reading
Understanding the Trade Desk Class Action Lawsuit Trade Desk, Inc., renowned for its innovative advertising technology, is currently facing a class action lawsuit that has captured the attention of many investors and legal experts alike. The lawsuit, recently filed, comes on the heels of troubling financial results indicating severe challenges in the company's recent...
Continue Reading
Kalmar Corporation's Upcoming Financial Statements Review Kalmar Corporation is gearing up to unveil its much-anticipated financial statements review for the year 2024. Scheduled for release at approximately 9:00 a.m. EET, the report promises to offer a comprehensive look into the company’s financial health and operational successes over the past year. Details About the...
Continue Reading
Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...
Continue Reading